Stock Updates

A look at a High Market Cap Stock: Celgene Corporation, CELG

Celgene Corporation, CELG is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Celgene Corporation, CELG  has a market cap of 76319.77. Since its IPO date on the 3/26/1990, Celgene Corporation, CELG performance year to date is -17.75%. Today Celgene Corporation, CELG has gained -2.12%, with a current price of 98.5.

Ownership of the company is 0.20% for insider ownership while institutional ownership is 79.30%. The management of the company have seen the company have a payout ratio of 0.00%. Return of assets are at 7.20%, with return on investment at 8.90%.

In terms of debt levels and profit levels, Celgene Corporation, CELG is seeing a long-term debt/equity of 2.58. While Total debt/equity is 0. With a profit margin of 18.90%, this is combined with a gross margin of 95.70%, and operating margin of 27.10%. Celgene Corporation ability to meet debt levels, with a current ratio of 4.6, while the quick ratio is 4.4.

For the last year Celgene Corporation, CELG has seen a EPS growth of -18.80%. A performance for the year of -16.19%. The 52-week high is -23.28%, and the 52-week low is 5.86%. The average volume for Celgene Corporation, CELG is 4309220.

With a target price of 137.35, can Celgene Corporation, CELG reach this target? Looking at the value indicators of Celgene Corporation, CELG. Celgene Corporation has a P/E of 41.35 and a forward P/E of 14.09. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.89. Celgene Corporation also has a P/S and a P/B of 7.51 and 13.78 respectively. For P/cash, Celgene Corporation has a value of 11.92, while it is 25.79 for P/free cash flow.

At the current price of 98.5, Celgene Corporation has a dividend yield of *TBA. We see a return on equity of 35.10%.

Looking more long-term Celgene Corporation, is projected to get an EPS growth for the next five years of 21.87%. In the short-term an EPS growth of 22.47% in the next year is forecasted. This is after a EPS growth of -18.80% for this year and for the last five years a 15.70% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment